[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Nepentes Pharma Sp z oo - Strategy, SWOT and Corporate Finance Report

January 2017 | 19 pages | ID: NC394B702B0EN
MarketLine

US$ 175.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Nepentes Pharma Sp z oo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

KEY FINDINGS
  • Detailed information on Nepentes Pharma Sp z oo required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Nepentes Pharma Sp z oo in the form of a SWOT analysis
  • An in-depth view of the business model of Nepentes Pharma Sp z oo including a breakdown and examination of key business segments
  • Intelligence on Nepentes Pharma Sp z oo's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Nepentes Pharma Sp z oo, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
REASONS TO BUY
  • Gain understanding of Nepentes Pharma Sp z oo and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Nepentes Pharma Sp z oo as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Nepentes Pharma Sp z oo's business structure, strategy and prospects.
KEY HIGHLIGHTS

Nepentes Pharma Sp z oo (Nepentes) is a pharmaceutical company based in Poland. The company develops, manufactures and sells formulations and solutions of dermatology, paediatrics and cough and cold. Its products are marketed under Iwostin, Emolium, Elixine, Propodia and Propolki brands. The company sells its products across Poland and other countries of the central and Eastern Europe region. In addition, the company sells various internationally-recognized pharmaceutical brands, comprising neo-angin, Sudocrem, Melisana Klosterfrau and Marimer. It owns and manages a production facility in Chociw, Poland. The company also operates through its affiliates in Bulgaria and Romania. Nepentes is headquartered in Warsaw, Poland.
Company Snapshot
  Nepentes Pharma Sp z oo: Company Overview
  Nepentes Pharma Sp z oo: Overview and Key Facts
    Nepentes Pharma Sp z oo: Overview
    Nepentes Pharma Sp z oo: Key Facts
  Nepentes Pharma Sp z oo: Key Employees
  Nepentes Pharma Sp z oo: Major Products and Services
  Nepentes Pharma Sp z oo: Company History
  Nepentes Pharma Sp z oo: Management Statement
  Nepentes Pharma Sp z oo: Locations and Subsidiaries
  Nepentes Pharma Sp z oo: Key Competitors
Nepentes Pharma Sp z oo: Company Analysis
  Nepentes Pharma Sp z oo: Business Description
  Nepentes Pharma Sp z oo: SWOT Analysis
    Nepentes Pharma Sp z oo: SWOT Overview
    Nepentes Pharma Sp z oo: Strengths
    Nepentes Pharma Sp z oo: Weaknesses
    Nepentes Pharma Sp z oo: Opportunities
    Nepentes Pharma Sp z oo: Threats
Appendix
  Contact Us
  Methodology
  Definitions
  About Datamonitor

LIST OF TABLES

Table 1: Nepentes Pharma Sp z oo: Key Facts
Table 2: Nepentes Pharma Sp z oo: Key Employees
Table 4: Nepentes Pharma Sp z oo: Key Competitors

COMPANIES MENTIONED

Nepentes Pharma Sp z oo


More Publications